The human PXR has been suggested to play an important role in MDR in cancers because of the upregulation of its expression in different cancer cells, its great flexibility in recognizing structurally diverse compounds, and its role as a master regulator of a three-phase detoxification system (9). The gene discussed is NR1I2; the disease is cancer.